Search research articles
Contact Us
Filters
Showing results (711-720 of 721) with videos related to
Page
of 73
Sort By:
The Lancet. Oncology
|
August 4, 2023
Designing clinical trials based on modern imaging and metastasis-directed treatments in patients with oligometastatic breast cancer: a consensus recommendation from the EORTC Imaging and Breast Cancer Groups
David Pasquier, Luc Bidaut, Daniela Elena Oprea-Lager, et al.
The Lancet. Oncology
|
June 29, 2026
European guideline for imaging of primary paediatric and adult osteosarcoma and Ewing sarcoma: systematic review and joint statement by the FOSTER consortium, Euro Ewing Consortium, European Society of Paediatric Radiology, and the European Association of Nuclear Medicine
Laura M E Adriaansen, Johannes H M Merks, Elvira C van Dalen, et al.
JCO Clinical Cancer Informatics
|
November 9, 2020
Joint Imaging Platform for Federated Clinical Data Analytics
Jonas Scherer, Marco Nolden, Jens Kleesiek, et al.
The Lancet. Oncology
|
October 3, 2024
Radiotherapy and theranostics: a Lancet Oncology Commission
May Abdel-Wahab, Francesco Giammarile, Mauro Carrara, et al.
The Lancet. Oncology
|
March 12, 2026
New prostate cancer risk groups by PSMA-PET (PPP3): an international, retrospective, registry-based cohort study
Madeleine J Karpinski, Caner Civan, Isabel Rauscher, et al.
European Urology
|
July 3, 2026
Diagnosis and Staging of Patients with Prostate Cancer: Report from the 2025 Advanced Prostate Cancer Consensus Conference (APCCC) Diagnostics
Stefano Fanti, Fabio Turco, Bertrand Tombal, et al.
European Urology
|
November 23, 2019
EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort<sup>†</sup>: Under the Auspices of the EAU-ESMO Guidelines Committees
J Alfred Witjes, Marek Babjuk, Joaquim Bellmunt, et al.
European Urology
|
December 9, 2022
Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022
Silke Gillessen, Alberto Bossi, Ian D Davis, et al.
European Urology
|
May 25, 2020
Corrigendum to 'EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort Under the Auspices of the EAU-ESMO Guidelines Committees' [European Urology 77 (2020) 223-250]
J Alfred Witjes, Marek Babjuk, Joaquim Bellmunt, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 1, 2023
Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022
Silke Gillessen, Alberto Bossi, Ian D Davis, et al.
Page
of 73
Search research articles
Search
Showing results (711-720 of 721) with videos related to
Sort By:
Page
of 73
The Lancet. Oncology
|
August 4, 2023
Designing clinical trials based on modern imaging and metastasis-directed treatments in patients with oligometastatic breast cancer: a consensus recommendation from the EORTC Imaging and Breast Cancer Groups
David Pasquier, Luc Bidaut, Daniela Elena Oprea-Lager, et al.
The Lancet. Oncology
|
June 29, 2026
European guideline for imaging of primary paediatric and adult osteosarcoma and Ewing sarcoma: systematic review and joint statement by the FOSTER consortium, Euro Ewing Consortium, European Society of Paediatric Radiology, and the European Association of Nuclear Medicine
Laura M E Adriaansen, Johannes H M Merks, Elvira C van Dalen, et al.
JCO Clinical Cancer Informatics
|
November 9, 2020
Joint Imaging Platform for Federated Clinical Data Analytics
Jonas Scherer, Marco Nolden, Jens Kleesiek, et al.
The Lancet. Oncology
|
October 3, 2024
Radiotherapy and theranostics: a Lancet Oncology Commission
May Abdel-Wahab, Francesco Giammarile, Mauro Carrara, et al.
The Lancet. Oncology
|
March 12, 2026
New prostate cancer risk groups by PSMA-PET (PPP3): an international, retrospective, registry-based cohort study
Madeleine J Karpinski, Caner Civan, Isabel Rauscher, et al.
European Urology
|
July 3, 2026
Diagnosis and Staging of Patients with Prostate Cancer: Report from the 2025 Advanced Prostate Cancer Consensus Conference (APCCC) Diagnostics
Stefano Fanti, Fabio Turco, Bertrand Tombal, et al.
European Urology
|
November 23, 2019
EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort<sup>†</sup>: Under the Auspices of the EAU-ESMO Guidelines Committees
J Alfred Witjes, Marek Babjuk, Joaquim Bellmunt, et al.
European Urology
|
December 9, 2022
Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022
Silke Gillessen, Alberto Bossi, Ian D Davis, et al.
European Urology
|
May 25, 2020
Corrigendum to 'EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort Under the Auspices of the EAU-ESMO Guidelines Committees' [European Urology 77 (2020) 223-250]
J Alfred Witjes, Marek Babjuk, Joaquim Bellmunt, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 1, 2023
Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022
Silke Gillessen, Alberto Bossi, Ian D Davis, et al.
Page
of 73